Total Payments
$3,717
2024 Payments
$104.24
Companies
33
Transactions
183
Medicare Patients
765
Medicare Billing
$124,651
Payment Breakdown by Category
Food & Beverage$3,637 (97.8%)
Education$79.99 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,637 | 182 | 97.8% |
| Education | $79.99 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $697.47 | 43 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $297.14 | 14 | $0 (2024) |
| Biogen, Inc. | $218.74 | 8 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $209.26 | 11 | $0 (2022) |
| Genentech USA, Inc. | $195.79 | 9 | $0 (2021) |
| Amgen Inc. | $170.83 | 8 | $0 (2022) |
| GENZYME CORPORATION | $170.38 | 3 | $0 (2022) |
| Allergan, Inc. | $168.50 | 10 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $150.74 | 9 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $134.77 | 12 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.24 | 5 | ARGENX US, INC. ($31.00) |
| 2023 | $259.27 | 10 | AbbVie Inc. ($144.97) |
| 2022 | $820.86 | 53 | ABBVIE INC. ($287.50) |
| 2021 | $1,039 | 57 | AbbVie Inc. ($265.00) |
| 2020 | $226.78 | 12 | Allergan, Inc. ($46.91) |
| 2019 | $604.97 | 20 | US WorldMeds, LLC ($124.23) |
| 2018 | $190.04 | 9 | PORTOLA PHARMACEUTICALS, INC. ($31.31) |
| 2017 | $471.17 | 17 | GENZYME CORPORATION ($140.62) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Neuropsychiatry | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/17/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Immunology | ||||||
| 07/17/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Immunology | ||||||
| 12/05/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.48 | General |
| Category: Neuroscience | ||||||
| 07/06/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 05/05/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $35.12 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/16/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/07/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.41 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/16/2022 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $39.31 | General |
| Category: Structural Heart | ||||||
| 11/15/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: PRIMARY CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 115 | 180 | $44,803 | $18,435 |
| 2022 | 5 | 220 | 295 | $82,735 | $35,040 |
| 2021 | 7 | 245 | 339 | $102,920 | $43,491 |
| 2020 | 5 | 185 | 254 | $74,028 | $27,686 |
Total Patients
765
Total Services
1,068
Medicare Billing
$124,651
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 105 | $25,200 | $10,065 | 39.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 34 | $10,959 | $4,765 | 43.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 21 | 41 | $8,644 | $3,605 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 139 | $33,360 | $14,547 | 43.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 42 | 42 | $19,142 | $7,554 | 39.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 41 | 74 | $15,601 | $6,821 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 27 | $8,703 | $4,007 | 46.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 13 | 13 | $5,929 | $2,111 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 127 | $30,480 | $13,232 | 43.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 56 | 56 | $25,523 | $10,432 | 40.9% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 41 | 86 | $18,131 | $8,152 | 45.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 27 | $8,703 | $3,972 | 45.6% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 20 | 20 | $9,122 | $3,295 | 36.1% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 11 | 11 | $6,600 | $2,630 | 39.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $4,362 | $1,778 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 69 | 107 | $25,680 | $8,652 | 33.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 39 | 39 | $17,775 | $6,963 | 39.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 34 | 62 | $13,071 | $5,536 | 42.4% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 20 | 20 | $9,122 | $3,400 | 37.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 23 | 26 | $8,380 | $3,134 | 37.4% |
About Dr. Alan Cohen, M.D
Dr. Alan Cohen, M.D is a Neurology healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902843659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Cohen, M.D has received a total of $3,717 in payments from pharmaceutical and medical device companies, with $104.24 received in 2024. These payments were reported across 183 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,637).
As a Medicare-enrolled provider, Cohen has provided services to 765 Medicare beneficiaries, totaling 1,068 services with total Medicare billing of $124,651. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Los Alamitos, CA
- Active Since 06/01/2006
- Last Updated 09/03/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1902843659
Products in Payments
- UBRELVY (Drug) $411.40
- NUPLAZID (Drug) $297.14
- NURTEC ODT (Drug) $255.28
- QULIPTA (Drug) $228.81
- OCREVUS (Biological) $195.79
- Aimovig (Biological) $170.83
- BOTOX (Biological) $155.85
- AUBAGIO (Drug) $152.36
- Xadago (Drug) $124.23
- SPINRAZA (Biological) $115.45
- AJOVY (Biological) $112.38
- TYSABRI (Biological) $90.33
- KESIMPTA (Drug) $87.79
- INGREZZA (Drug) $74.51
- Vimpat (Drug) $58.96
- BAFIERTAM (Drug) $57.93
- Ongentys (Drug) $52.24
- BRILINTA (Drug) $47.13
- SOLIRIS (Drug) $46.60
- AIMOVIG (Biological) $45.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Los Alamitos
Dr. Nirav Patel, M.d, M.D
Neurology — Payments: $848,036
Neurology $848,036
Dr. Omid Omidvar, M.d, M.D
Neurology — Payments: $33,376
Neurology $33,376
Dr. David Rosenberg, M.d, M.D
Neurology — Payments: $10,685
Neurology $10,685
Dr. Nima Ramezan Arab, M.d, M.D
Neurology — Payments: $6,841
Neurology $6,841
Yamin Shwe, Md, MD
Neurology — Payments: $4,909
Neurology $4,909
Dr. Mohan Tadikonda, M.d, M.D
Neurology — Payments: $247.80
Neurology $247.80